Crainio
Crainio is a UK-based medical technology company focused on revolutionizing the measurement of intracranial pressure (ICP) through a non-invasive, real-time, and affordable device. Their mission is to improve the diagnosis and treatment of traumatic brain injury (TBI) by providing clinicians with continuous ICP monitoring without the need for invasive procedures. Using low-power infrared light and advanced machine learning algorithms, Crainio's technology aims to make ICP measurement accessible, safe, and effective for a wide range of healthcare settings.
Industries
N/A
Nr. of Employees
small (1-50)
Crainio is currently seeking investment
Crainio is seeking a series-a investment in the range of 1m-5m
Products
Non-invasive ICP measurement system (forehead probe and algorithm)
Integrated system consisting of a forehead-mounted optical probe and machine-learning algorithm that processes optical pulse signals to provide continuous, real-time estimates of intracranial pressure without invasive probes.
Non-invasive ICP measurement system (forehead probe and algorithm)
Integrated system consisting of a forehead-mounted optical probe and machine-learning algorithm that processes optical pulse signals to provide continuous, real-time estimates of intracranial pressure without invasive probes.
Expertise Areas
- Non-invasive intracranial pressure monitoring
- Optical sensing and photoplethysmography
- Machine learning for biomedical signal processing
- Clinical trial management in neurotrauma
Key Technologies
- Photoplethysmography (PPG)
- Near-infrared optical sensing
- Machine learning / deep learning for signal processing
- Real-time signal processing
Key People
Chief Scientist
Head of Data Science
Chief Scientist
Head of Data Science
News & Updates
Crainio received a significant £500K grant from the Innovate UK Biomedical Catalyst programme, in collaboration with City, University of London and Barts NHS Trust, to enable a clinical feasibility study for its non-invasive ICP technology.
Crainio received a significant grant from the NIHR FAST programme to further develop its non-invasive ICP technology, focusing on enhancements to the sensor design and research on optimization.
Maria Roldan, Crainio’s CTO, won the Worshipful Company of Engineers Mercia Award 2022 for her research on Non-invasive Multimodal Monitoring in Traumatic Brain Injury.
Dr Tomas Abay received the Gold Medal for Engineering at the STEM for Britain awards for early work on the technology behind Crainio.
Crainio received a significant £500K grant from the Innovate UK Biomedical Catalyst programme, in collaboration with City, University of London and Barts NHS Trust, to enable a clinical feasibility study for its non-invasive ICP technology.
Crainio received a significant grant from the NIHR FAST programme to further develop its non-invasive ICP technology, focusing on enhancements to the sensor design and research on optimization.
Maria Roldan, Crainio’s CTO, won the Worshipful Company of Engineers Mercia Award 2022 for her research on Non-invasive Multimodal Monitoring in Traumatic Brain Injury.
Dr Tomas Abay received the Gold Medal for Engineering at the STEM for Britain awards for early work on the technology behind Crainio.